Antimicrobial Stewardship-Based Integration of Rapid Molecular Diagnostics and PCT for Pneumonia

Pneumonia is the most common clinical indication for antibiotics in the ICU and much of that use is unnecessarily broad. Trevor Van Schooneveld, MD, discusses how rapid molecular tools and biomarkers can help define the etiology of pneumonia, refine antibiotic choices, and determine patient-specific treatment durations.
This session was organized by bioMérieux (www.biomerieux.com) and presented during the Society of Critical Care Medicine’s (SCCM) 2023 Critical Care Congress.
SCCM offers various sponsorship and advertising opportunities for industry partners to promote their brand launches or current therapies, conduct a focused program on disease awareness, or discuss their current pipeline activity.
The views and opinions expressed are those of the sponsor and do not necessarily reflect the views or opinions of SCCM. References to specific commercial entities, products, tests, procedures, opinions, resources, and information do not reflect SCCM’s review or endorsement.